Diagnamed Holdings Corp. (CSE:DMED)
0.0350
0.00 (0.00%)
Mar 28, 2025, 3:51 PM EST
Diagnamed Holdings Statistics
Total Valuation
CSE:DMED has a market cap or net worth of CAD 2.50 million. The enterprise value is 2.39 million.
Market Cap | 2.50M |
Enterprise Value | 2.39M |
Important Dates
The next estimated earnings date is Monday, May 26, 2025.
Earnings Date | May 26, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CSE:DMED has 83.41 million shares outstanding. The number of shares has increased by 1.37% in one year.
Current Share Class | n/a |
Shares Outstanding | 83.41M |
Shares Change (YoY) | +1.37% |
Shares Change (QoQ) | +0.88% |
Owned by Insiders (%) | 11.93% |
Owned by Institutions (%) | n/a |
Float | 73.22M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -3.54 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.36
Current Ratio | 0.36 |
Quick Ratio | 0.35 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -411.93 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -109.64% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 214.04% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.50% in the last 52 weeks. The beta is -2.34, so CSE:DMED's price volatility has been lower than the market average.
Beta (5Y) | -2.34 |
52-Week Price Change | -12.50% |
50-Day Moving Average | 0.03 |
200-Day Moving Average | 0.02 |
Relative Strength Index (RSI) | 50.36 |
Average Volume (20 Days) | 203,500 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -626,545 |
Pretax Income | -674,889 |
Net Income | -674,889 |
EBITDA | n/a |
EBIT | -626,545 |
Earnings Per Share (EPS) | -0.01 |
Balance Sheet
The company has 114,332 in cash and n/a in debt, giving a net cash position of 114,332 or 0.00 per share.
Cash & Cash Equivalents | 114,332 |
Total Debt | n/a |
Net Cash | 114,332 |
Net Cash Per Share | 0.00 |
Equity (Book Value) | -292,718 |
Book Value Per Share | -0.00 |
Working Capital | -292,718 |
Cash Flow
Operating Cash Flow | -350,791 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CSE:DMED does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.37% |
Shareholder Yield | -1.37% |
Earnings Yield | -26.97% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |